Summary: Recent studies have shown the potential of deep learning algorithms in predicting overall survival (OS) in hepatocellular carcinoma (HCC) patients. These innovative approaches, combined with radiomics, aim to address the challenges of clinical heterogeneity. While deep learning models have shown promise,